nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—Cytochrome P450 3A Inhibitors—Crizotinib—lung cancer	0.341	0.616	CiPCiCtD
Telaprevir—P-Glycoprotein Inhibitors—Crizotinib—lung cancer	0.213	0.385	CiPCiCtD
Telaprevir—ALB—lung cancer	0.0672	0.512	CbGaD
Telaprevir—ABCB1—lung cancer	0.0642	0.488	CbGaD
Telaprevir—ORM1—Gefitinib—lung cancer	0.037	0.185	CbGbCtD
Telaprevir—ORM1—Erlotinib—lung cancer	0.0219	0.11	CbGbCtD
Telaprevir—ALB—Gefitinib—lung cancer	0.0156	0.078	CbGbCtD
Telaprevir—ALB—Erlotinib—lung cancer	0.0092	0.0461	CbGbCtD
Telaprevir—ABCB1—Topotecan—lung cancer	0.0089	0.0446	CbGbCtD
Telaprevir—ALB—Irinotecan—lung cancer	0.00831	0.0417	CbGbCtD
Telaprevir—ABCB1—Gefitinib—lung cancer	0.00814	0.0408	CbGbCtD
Telaprevir—ABCB1—Vinorelbine—lung cancer	0.00627	0.0314	CbGbCtD
Telaprevir—CYP3A4—Topotecan—lung cancer	0.00533	0.0267	CbGbCtD
Telaprevir—ABCB1—Crizotinib—lung cancer	0.00499	0.025	CbGbCtD
Telaprevir—CYP3A4—Gefitinib—lung cancer	0.00488	0.0245	CbGbCtD
Telaprevir—ABCB1—Gemcitabine—lung cancer	0.00488	0.0245	CbGbCtD
Telaprevir—ABCB1—Erlotinib—lung cancer	0.00481	0.0241	CbGbCtD
Telaprevir—CYP3A4—Teniposide—lung cancer	0.00473	0.0237	CbGbCtD
Telaprevir—ABCB1—Paclitaxel—lung cancer	0.00441	0.0221	CbGbCtD
Telaprevir—ALB—Methotrexate—lung cancer	0.0044	0.0221	CbGbCtD
Telaprevir—ABCB1—Irinotecan—lung cancer	0.00435	0.0218	CbGbCtD
Telaprevir—ABCB1—Vinblastine—lung cancer	0.00386	0.0194	CbGbCtD
Telaprevir—CYP3A4—Vinorelbine—lung cancer	0.00376	0.0188	CbGbCtD
Telaprevir—ABCB1—Cisplatin—lung cancer	0.00354	0.0178	CbGbCtD
Telaprevir—ABCB1—Etoposide—lung cancer	0.00348	0.0175	CbGbCtD
Telaprevir—ABCB1—Docetaxel—lung cancer	0.00319	0.016	CbGbCtD
Telaprevir—CYP3A4—Crizotinib—lung cancer	0.00299	0.015	CbGbCtD
Telaprevir—CYP3A4—Erlotinib—lung cancer	0.00288	0.0145	CbGbCtD
Telaprevir—CYP3A4—Paclitaxel—lung cancer	0.00264	0.0132	CbGbCtD
Telaprevir—CYP3A4—Irinotecan—lung cancer	0.0026	0.0131	CbGbCtD
Telaprevir—ABCB1—Doxorubicin—lung cancer	0.00237	0.0119	CbGbCtD
Telaprevir—CYP3A4—Vinblastine—lung cancer	0.00232	0.0116	CbGbCtD
Telaprevir—ABCB1—Methotrexate—lung cancer	0.0023	0.0115	CbGbCtD
Telaprevir—CYP3A4—Etoposide—lung cancer	0.00209	0.0105	CbGbCtD
Telaprevir—CYP3A4—Docetaxel—lung cancer	0.00191	0.00957	CbGbCtD
Telaprevir—CMA1—respiratory system—lung cancer	0.00167	0.0977	CbGeAlD
Telaprevir—CTSK—mammary gland—lung cancer	0.00161	0.0945	CbGeAlD
Telaprevir—CYP3A4—Doxorubicin—lung cancer	0.00142	0.00713	CbGbCtD
Telaprevir—CTSK—respiratory system—lung cancer	0.00108	0.063	CbGeAlD
Telaprevir—CMA1—bone marrow—lung cancer	0.000978	0.0573	CbGeAlD
Telaprevir—CTSS—respiratory system—lung cancer	0.000943	0.0552	CbGeAlD
Telaprevir—CMA1—lung—lung cancer	0.000886	0.0519	CbGeAlD
Telaprevir—CTSK—bronchus—lung cancer	0.000885	0.0518	CbGeAlD
Telaprevir—CTSK—trachea—lung cancer	0.000795	0.0465	CbGeAlD
Telaprevir—CTSS—bronchus—lung cancer	0.000776	0.0454	CbGeAlD
Telaprevir—CTSK—cardiac atrium—lung cancer	0.000747	0.0437	CbGeAlD
Telaprevir—ALB—mammary gland—lung cancer	0.000741	0.0433	CbGeAlD
Telaprevir—CTSS—trachea—lung cancer	0.000697	0.0408	CbGeAlD
Telaprevir—CTSK—bone marrow—lung cancer	0.000631	0.0369	CbGeAlD
Telaprevir—CMA1—lymph node—lung cancer	0.000606	0.0355	CbGeAlD
Telaprevir—CTSK—lung—lung cancer	0.000571	0.0334	CbGeAlD
Telaprevir—CTSS—bone marrow—lung cancer	0.000552	0.0323	CbGeAlD
Telaprevir—CTSS—lung—lung cancer	0.000501	0.0293	CbGeAlD
Telaprevir—Boceprevir—ABCB1—lung cancer	0.000449	1	CrCbGaD
Telaprevir—CTSK—lymph node—lung cancer	0.000391	0.0229	CbGeAlD
Telaprevir—CTSS—lymph node—lung cancer	0.000342	0.02	CbGeAlD
Telaprevir—ORM1—bone marrow—lung cancer	0.00033	0.0193	CbGeAlD
Telaprevir—ORM1—lung—lung cancer	0.000299	0.0175	CbGeAlD
Telaprevir—ORM1—lymph node—lung cancer	0.000204	0.012	CbGeAlD
Telaprevir—ALB—lymph node—lung cancer	0.000179	0.0105	CbGeAlD
Telaprevir—ABCB1—respiratory system—lung cancer	0.000166	0.00973	CbGeAlD
Telaprevir—ABCB1—epithelium—lung cancer	0.000139	0.00813	CbGeAlD
Telaprevir—ABCB1—trachea—lung cancer	0.000123	0.00719	CbGeAlD
Telaprevir—Erythema multiforme—Gemcitabine—lung cancer	0.000101	0.00189	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Etoposide—lung cancer	0.000101	0.00188	CcSEcCtD
Telaprevir—Infestation—Paclitaxel—lung cancer	9.97e-05	0.00186	CcSEcCtD
Telaprevir—Infestation NOS—Paclitaxel—lung cancer	9.97e-05	0.00186	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Paclitaxel—lung cancer	9.88e-05	0.00184	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Docetaxel—lung cancer	9.87e-05	0.00184	CcSEcCtD
Telaprevir—Urinary tract disorder—Cisplatin—lung cancer	9.84e-05	0.00184	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—lung cancer	9.79e-05	0.00183	CcSEcCtD
Telaprevir—Urethral disorder—Cisplatin—lung cancer	9.76e-05	0.00182	CcSEcCtD
Telaprevir—ABCB1—bone marrow—lung cancer	9.75e-05	0.0057	CbGeAlD
Telaprevir—Hepatobiliary disease—Etoposide—lung cancer	9.61e-05	0.00179	CcSEcCtD
Telaprevir—Blood uric acid increased—Doxorubicin—lung cancer	9.6e-05	0.00179	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Topotecan—lung cancer	9.54e-05	0.00178	CcSEcCtD
Telaprevir—Fatigue—Topotecan—lung cancer	9.52e-05	0.00178	CcSEcCtD
Telaprevir—Vomiting—Teniposide—lung cancer	9.48e-05	0.00177	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Erlotinib—lung cancer	9.44e-05	0.00176	CcSEcCtD
Telaprevir—Hepatobiliary disease—Paclitaxel—lung cancer	9.43e-05	0.00176	CcSEcCtD
Telaprevir—Fatigue—Erlotinib—lung cancer	9.42e-05	0.00176	CcSEcCtD
Telaprevir—Rash—Teniposide—lung cancer	9.4e-05	0.00175	CcSEcCtD
Telaprevir—Dermatitis—Teniposide—lung cancer	9.39e-05	0.00175	CcSEcCtD
Telaprevir—Infection—Vinorelbine—lung cancer	9.39e-05	0.00175	CcSEcCtD
Telaprevir—Eye disorder—Cisplatin—lung cancer	9.31e-05	0.00174	CcSEcCtD
Telaprevir—Nervous system disorder—Vinorelbine—lung cancer	9.27e-05	0.00173	CcSEcCtD
Telaprevir—Thrombocytopenia—Vinorelbine—lung cancer	9.25e-05	0.00173	CcSEcCtD
Telaprevir—Skin disorder—Vinorelbine—lung cancer	9.18e-05	0.00171	CcSEcCtD
Telaprevir—Urinary tract disorder—Etoposide—lung cancer	9.01e-05	0.00168	CcSEcCtD
Telaprevir—Candida infection—Doxorubicin—lung cancer	9e-05	0.00168	CcSEcCtD
Telaprevir—Urethral disorder—Etoposide—lung cancer	8.94e-05	0.00167	CcSEcCtD
Telaprevir—Nausea—Teniposide—lung cancer	8.85e-05	0.00165	CcSEcCtD
Telaprevir—Urinary tract disorder—Paclitaxel—lung cancer	8.83e-05	0.00165	CcSEcCtD
Telaprevir—ABCB1—lung—lung cancer	8.83e-05	0.00517	CbGeAlD
Telaprevir—Anaemia—Irinotecan—lung cancer	8.83e-05	0.00165	CcSEcCtD
Telaprevir—Oedema peripheral—Paclitaxel—lung cancer	8.81e-05	0.00164	CcSEcCtD
Telaprevir—Urticaria—Topotecan—lung cancer	8.78e-05	0.00164	CcSEcCtD
Telaprevir—Urethral disorder—Paclitaxel—lung cancer	8.77e-05	0.00164	CcSEcCtD
Telaprevir—Malnutrition—Cisplatin—lung cancer	8.67e-05	0.00162	CcSEcCtD
Telaprevir—Erythema multiforme—Etoposide—lung cancer	8.63e-05	0.00161	CcSEcCtD
Telaprevir—Anaemia—Gemcitabine—lung cancer	8.6e-05	0.0016	CcSEcCtD
Telaprevir—Syncope—Irinotecan—lung cancer	8.56e-05	0.0016	CcSEcCtD
Telaprevir—Renal failure acute—Methotrexate—lung cancer	8.56e-05	0.0016	CcSEcCtD
Telaprevir—Eye disorder—Etoposide—lung cancer	8.53e-05	0.00159	CcSEcCtD
Telaprevir—Erythema multiforme—Paclitaxel—lung cancer	8.46e-05	0.00158	CcSEcCtD
Telaprevir—Infestation—Docetaxel—lung cancer	8.45e-05	0.00158	CcSEcCtD
Telaprevir—Infestation NOS—Docetaxel—lung cancer	8.45e-05	0.00158	CcSEcCtD
Telaprevir—Loss of consciousness—Irinotecan—lung cancer	8.39e-05	0.00157	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Docetaxel—lung cancer	8.37e-05	0.00156	CcSEcCtD
Telaprevir—Eye disorder—Paclitaxel—lung cancer	8.36e-05	0.00156	CcSEcCtD
Telaprevir—Asthenia—Vinblastine—lung cancer	8.16e-05	0.00152	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Vinorelbine—lung cancer	8.16e-05	0.00152	CcSEcCtD
Telaprevir—Fatigue—Vinorelbine—lung cancer	8.15e-05	0.00152	CcSEcCtD
Telaprevir—Anaemia—Cisplatin—lung cancer	8.01e-05	0.0015	CcSEcCtD
Telaprevir—Hepatobiliary disease—Docetaxel—lung cancer	7.99e-05	0.00149	CcSEcCtD
Telaprevir—Asthenia—Topotecan—lung cancer	7.93e-05	0.00148	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	7.86e-05	0.00147	CcSEcCtD
Telaprevir—Asthenia—Erlotinib—lung cancer	7.84e-05	0.00146	CcSEcCtD
Telaprevir—Pruritus—Topotecan—lung cancer	7.82e-05	0.00146	CcSEcCtD
Telaprevir—Malnutrition—Paclitaxel—lung cancer	7.79e-05	0.00145	CcSEcCtD
Telaprevir—Diarrhoea—Vinblastine—lung cancer	7.78e-05	0.00145	CcSEcCtD
Telaprevir—Dysgeusia—Etoposide—lung cancer	7.78e-05	0.00145	CcSEcCtD
Telaprevir—Infection—Irinotecan—lung cancer	7.74e-05	0.00144	CcSEcCtD
Telaprevir—Pruritus—Erlotinib—lung cancer	7.73e-05	0.00144	CcSEcCtD
Telaprevir—Shock—Irinotecan—lung cancer	7.67e-05	0.00143	CcSEcCtD
Telaprevir—Nervous system disorder—Irinotecan—lung cancer	7.64e-05	0.00143	CcSEcCtD
Telaprevir—Thrombocytopenia—Irinotecan—lung cancer	7.63e-05	0.00142	CcSEcCtD
Telaprevir—Dysgeusia—Paclitaxel—lung cancer	7.63e-05	0.00142	CcSEcCtD
Telaprevir—Eczema—Doxorubicin—lung cancer	7.61e-05	0.00142	CcSEcCtD
Telaprevir—Diarrhoea—Topotecan—lung cancer	7.56e-05	0.00141	CcSEcCtD
Telaprevir—Infection—Gemcitabine—lung cancer	7.54e-05	0.00141	CcSEcCtD
Telaprevir—Dizziness—Vinblastine—lung cancer	7.52e-05	0.0014	CcSEcCtD
Telaprevir—Urticaria—Vinorelbine—lung cancer	7.51e-05	0.0014	CcSEcCtD
Telaprevir—Urinary tract disorder—Docetaxel—lung cancer	7.49e-05	0.0014	CcSEcCtD
Telaprevir—Diarrhoea—Erlotinib—lung cancer	7.48e-05	0.0014	CcSEcCtD
Telaprevir—Oedema peripheral—Docetaxel—lung cancer	7.47e-05	0.00139	CcSEcCtD
Telaprevir—Nervous system disorder—Gemcitabine—lung cancer	7.44e-05	0.00139	CcSEcCtD
Telaprevir—Urethral disorder—Docetaxel—lung cancer	7.43e-05	0.00139	CcSEcCtD
Telaprevir—Thrombocytopenia—Gemcitabine—lung cancer	7.43e-05	0.00139	CcSEcCtD
Telaprevir—Renal failure acute—Doxorubicin—lung cancer	7.41e-05	0.00138	CcSEcCtD
Telaprevir—Skin disorder—Gemcitabine—lung cancer	7.37e-05	0.00138	CcSEcCtD
Telaprevir—Anaemia—Etoposide—lung cancer	7.34e-05	0.00137	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	7.33e-05	0.00137	CcSEcCtD
Telaprevir—Dizziness—Topotecan—lung cancer	7.3e-05	0.00136	CcSEcCtD
Telaprevir—Vomiting—Vinblastine—lung cancer	7.23e-05	0.00135	CcSEcCtD
Telaprevir—Dizziness—Erlotinib—lung cancer	7.23e-05	0.00135	CcSEcCtD
Telaprevir—Anaemia—Paclitaxel—lung cancer	7.2e-05	0.00134	CcSEcCtD
Telaprevir—Erythema multiforme—Docetaxel—lung cancer	7.17e-05	0.00134	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Methotrexate—lung cancer	7.11e-05	0.00133	CcSEcCtD
Telaprevir—Eye disorder—Docetaxel—lung cancer	7.09e-05	0.00132	CcSEcCtD
Telaprevir—Infection—Cisplatin—lung cancer	7.03e-05	0.00131	CcSEcCtD
Telaprevir—Vomiting—Topotecan—lung cancer	7.02e-05	0.00131	CcSEcCtD
Telaprevir—Syncope—Paclitaxel—lung cancer	6.98e-05	0.0013	CcSEcCtD
Telaprevir—Loss of consciousness—Etoposide—lung cancer	6.98e-05	0.0013	CcSEcCtD
Telaprevir—Rash—Topotecan—lung cancer	6.96e-05	0.0013	CcSEcCtD
Telaprevir—Dermatitis—Topotecan—lung cancer	6.96e-05	0.0013	CcSEcCtD
Telaprevir—Vomiting—Erlotinib—lung cancer	6.95e-05	0.0013	CcSEcCtD
Telaprevir—Nervous system disorder—Cisplatin—lung cancer	6.94e-05	0.00129	CcSEcCtD
Telaprevir—Thrombocytopenia—Cisplatin—lung cancer	6.93e-05	0.00129	CcSEcCtD
Telaprevir—Rash—Erlotinib—lung cancer	6.89e-05	0.00129	CcSEcCtD
Telaprevir—Dermatitis—Erlotinib—lung cancer	6.88e-05	0.00128	CcSEcCtD
Telaprevir—Skin disorder—Cisplatin—lung cancer	6.87e-05	0.00128	CcSEcCtD
Telaprevir—Loss of consciousness—Paclitaxel—lung cancer	6.84e-05	0.00128	CcSEcCtD
Telaprevir—Asthenia—Vinorelbine—lung cancer	6.78e-05	0.00127	CcSEcCtD
Telaprevir—Eosinophilia—Methotrexate—lung cancer	6.76e-05	0.00126	CcSEcCtD
Telaprevir—Nausea—Vinblastine—lung cancer	6.75e-05	0.00126	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Irinotecan—lung cancer	6.73e-05	0.00126	CcSEcCtD
Telaprevir—Fatigue—Irinotecan—lung cancer	6.72e-05	0.00125	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	6.72e-05	0.00125	CcSEcCtD
Telaprevir—Pruritus—Vinorelbine—lung cancer	6.69e-05	0.00125	CcSEcCtD
Telaprevir—Malnutrition—Docetaxel—lung cancer	6.6e-05	0.00123	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	6.58e-05	0.00123	CcSEcCtD
Telaprevir—Nausea—Topotecan—lung cancer	6.56e-05	0.00122	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Gemcitabine—lung cancer	6.55e-05	0.00122	CcSEcCtD
Telaprevir—Fatigue—Gemcitabine—lung cancer	6.55e-05	0.00122	CcSEcCtD
Telaprevir—Nausea—Erlotinib—lung cancer	6.49e-05	0.00121	CcSEcCtD
Telaprevir—Diarrhoea—Vinorelbine—lung cancer	6.47e-05	0.00121	CcSEcCtD
Telaprevir—Dysgeusia—Docetaxel—lung cancer	6.46e-05	0.00121	CcSEcCtD
Telaprevir—Infection—Etoposide—lung cancer	6.44e-05	0.0012	CcSEcCtD
Telaprevir—Blood creatinine increased—Doxorubicin—lung cancer	6.41e-05	0.0012	CcSEcCtD
Telaprevir—Thrombocytopenia—Etoposide—lung cancer	6.35e-05	0.00118	CcSEcCtD
Telaprevir—Infection—Paclitaxel—lung cancer	6.31e-05	0.00118	CcSEcCtD
Telaprevir—Skin disorder—Etoposide—lung cancer	6.3e-05	0.00117	CcSEcCtD
Telaprevir—Shock—Paclitaxel—lung cancer	6.25e-05	0.00117	CcSEcCtD
Telaprevir—Dizziness—Vinorelbine—lung cancer	6.25e-05	0.00117	CcSEcCtD
Telaprevir—Nervous system disorder—Paclitaxel—lung cancer	6.23e-05	0.00116	CcSEcCtD
Telaprevir—Hypokalaemia—Doxorubicin—lung cancer	6.23e-05	0.00116	CcSEcCtD
Telaprevir—Thrombocytopenia—Paclitaxel—lung cancer	6.22e-05	0.00116	CcSEcCtD
Telaprevir—Skin disorder—Paclitaxel—lung cancer	6.17e-05	0.00115	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Doxorubicin—lung cancer	6.16e-05	0.00115	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Cisplatin—lung cancer	6.11e-05	0.00114	CcSEcCtD
Telaprevir—Anaemia—Docetaxel—lung cancer	6.1e-05	0.00114	CcSEcCtD
Telaprevir—Infestation NOS—Methotrexate—lung cancer	6.09e-05	0.00114	CcSEcCtD
Telaprevir—Infestation—Methotrexate—lung cancer	6.09e-05	0.00114	CcSEcCtD
Telaprevir—ABCB1—lymph node—lung cancer	6.04e-05	0.00353	CbGeAlD
Telaprevir—Stevens-Johnson syndrome—Methotrexate—lung cancer	6.04e-05	0.00113	CcSEcCtD
Telaprevir—Vomiting—Vinorelbine—lung cancer	6.01e-05	0.00112	CcSEcCtD
Telaprevir—Rash—Vinorelbine—lung cancer	5.96e-05	0.00111	CcSEcCtD
Telaprevir—Dermatitis—Vinorelbine—lung cancer	5.95e-05	0.00111	CcSEcCtD
Telaprevir—Syncope—Docetaxel—lung cancer	5.92e-05	0.0011	CcSEcCtD
Telaprevir—Eosinophilia—Doxorubicin—lung cancer	5.85e-05	0.00109	CcSEcCtD
Telaprevir—Loss of consciousness—Docetaxel—lung cancer	5.8e-05	0.00108	CcSEcCtD
Telaprevir—Hepatobiliary disease—Methotrexate—lung cancer	5.76e-05	0.00107	CcSEcCtD
Telaprevir—Nausea—Vinorelbine—lung cancer	5.61e-05	0.00105	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Etoposide—lung cancer	5.6e-05	0.00104	CcSEcCtD
Telaprevir—Asthenia—Irinotecan—lung cancer	5.59e-05	0.00104	CcSEcCtD
Telaprevir—Fatigue—Etoposide—lung cancer	5.59e-05	0.00104	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	5.58e-05	0.00104	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Paclitaxel—lung cancer	5.49e-05	0.00102	CcSEcCtD
Telaprevir—Fatigue—Paclitaxel—lung cancer	5.48e-05	0.00102	CcSEcCtD
Telaprevir—Asthenia—Gemcitabine—lung cancer	5.45e-05	0.00102	CcSEcCtD
Telaprevir—Urinary tract disorder—Methotrexate—lung cancer	5.4e-05	0.00101	CcSEcCtD
Telaprevir—Pruritus—Gemcitabine—lung cancer	5.37e-05	0.001	CcSEcCtD
Telaprevir—Urethral disorder—Methotrexate—lung cancer	5.36e-05	0.001	CcSEcCtD
Telaprevir—Infection—Docetaxel—lung cancer	5.35e-05	0.000999	CcSEcCtD
Telaprevir—Diarrhoea—Irinotecan—lung cancer	5.33e-05	0.000995	CcSEcCtD
Telaprevir—Shock—Docetaxel—lung cancer	5.3e-05	0.000989	CcSEcCtD
Telaprevir—Nervous system disorder—Docetaxel—lung cancer	5.28e-05	0.000986	CcSEcCtD
Telaprevir—Thrombocytopenia—Docetaxel—lung cancer	5.27e-05	0.000984	CcSEcCtD
Telaprevir—Infestation—Doxorubicin—lung cancer	5.27e-05	0.000984	CcSEcCtD
Telaprevir—Infestation NOS—Doxorubicin—lung cancer	5.27e-05	0.000984	CcSEcCtD
Telaprevir—Skin disorder—Docetaxel—lung cancer	5.23e-05	0.000976	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Doxorubicin—lung cancer	5.23e-05	0.000975	CcSEcCtD
Telaprevir—Diarrhoea—Gemcitabine—lung cancer	5.19e-05	0.000969	CcSEcCtD
Telaprevir—Erythema multiforme—Methotrexate—lung cancer	5.17e-05	0.000964	CcSEcCtD
Telaprevir—Dizziness—Irinotecan—lung cancer	5.15e-05	0.000962	CcSEcCtD
Telaprevir—Urticaria—Etoposide—lung cancer	5.15e-05	0.000961	CcSEcCtD
Telaprevir—Eye disorder—Methotrexate—lung cancer	5.11e-05	0.000953	CcSEcCtD
Telaprevir—Asthenia—Cisplatin—lung cancer	5.08e-05	0.000947	CcSEcCtD
Telaprevir—Urticaria—Paclitaxel—lung cancer	5.05e-05	0.000942	CcSEcCtD
Telaprevir—Hepatobiliary disease—Doxorubicin—lung cancer	4.99e-05	0.00093	CcSEcCtD
Telaprevir—Vomiting—Irinotecan—lung cancer	4.96e-05	0.000925	CcSEcCtD
Telaprevir—Rash—Irinotecan—lung cancer	4.91e-05	0.000917	CcSEcCtD
Telaprevir—Dermatitis—Irinotecan—lung cancer	4.91e-05	0.000916	CcSEcCtD
Telaprevir—Diarrhoea—Cisplatin—lung cancer	4.84e-05	0.000903	CcSEcCtD
Telaprevir—Vomiting—Gemcitabine—lung cancer	4.83e-05	0.000901	CcSEcCtD
Telaprevir—Rash—Gemcitabine—lung cancer	4.79e-05	0.000893	CcSEcCtD
Telaprevir—Dermatitis—Gemcitabine—lung cancer	4.78e-05	0.000892	CcSEcCtD
Telaprevir—Malnutrition—Methotrexate—lung cancer	4.76e-05	0.000888	CcSEcCtD
Telaprevir—Urinary tract disorder—Doxorubicin—lung cancer	4.67e-05	0.000872	CcSEcCtD
Telaprevir—Oedema peripheral—Doxorubicin—lung cancer	4.66e-05	0.00087	CcSEcCtD
Telaprevir—Dysgeusia—Methotrexate—lung cancer	4.66e-05	0.000869	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Docetaxel—lung cancer	4.65e-05	0.000868	CcSEcCtD
Telaprevir—Asthenia—Etoposide—lung cancer	4.65e-05	0.000868	CcSEcCtD
Telaprevir—Fatigue—Docetaxel—lung cancer	4.64e-05	0.000867	CcSEcCtD
Telaprevir—Urethral disorder—Doxorubicin—lung cancer	4.64e-05	0.000866	CcSEcCtD
Telaprevir—Nausea—Irinotecan—lung cancer	4.63e-05	0.000864	CcSEcCtD
Telaprevir—Pruritus—Etoposide—lung cancer	4.59e-05	0.000856	CcSEcCtD
Telaprevir—Asthenia—Paclitaxel—lung cancer	4.56e-05	0.000851	CcSEcCtD
Telaprevir—Nausea—Gemcitabine—lung cancer	4.51e-05	0.000841	CcSEcCtD
Telaprevir—Vomiting—Cisplatin—lung cancer	4.5e-05	0.00084	CcSEcCtD
Telaprevir—Pruritus—Paclitaxel—lung cancer	4.5e-05	0.000839	CcSEcCtD
Telaprevir—Erythema multiforme—Doxorubicin—lung cancer	4.47e-05	0.000835	CcSEcCtD
Telaprevir—Rash—Cisplatin—lung cancer	4.46e-05	0.000833	CcSEcCtD
Telaprevir—Dermatitis—Cisplatin—lung cancer	4.46e-05	0.000832	CcSEcCtD
Telaprevir—Diarrhoea—Etoposide—lung cancer	4.44e-05	0.000828	CcSEcCtD
Telaprevir—Eye disorder—Doxorubicin—lung cancer	4.42e-05	0.000825	CcSEcCtD
Telaprevir—Anaemia—Methotrexate—lung cancer	4.4e-05	0.000821	CcSEcCtD
Telaprevir—Diarrhoea—Paclitaxel—lung cancer	4.35e-05	0.000811	CcSEcCtD
Telaprevir—Dizziness—Etoposide—lung cancer	4.29e-05	0.0008	CcSEcCtD
Telaprevir—Dizziness—Paclitaxel—lung cancer	4.2e-05	0.000784	CcSEcCtD
Telaprevir—Nausea—Cisplatin—lung cancer	4.2e-05	0.000784	CcSEcCtD
Telaprevir—Vomiting—Etoposide—lung cancer	4.12e-05	0.000769	CcSEcCtD
Telaprevir—Malnutrition—Doxorubicin—lung cancer	4.12e-05	0.000769	CcSEcCtD
Telaprevir—Rash—Etoposide—lung cancer	4.09e-05	0.000763	CcSEcCtD
Telaprevir—Dermatitis—Etoposide—lung cancer	4.08e-05	0.000762	CcSEcCtD
Telaprevir—Vomiting—Paclitaxel—lung cancer	4.04e-05	0.000754	CcSEcCtD
Telaprevir—Dysgeusia—Doxorubicin—lung cancer	4.03e-05	0.000753	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	4.02e-05	0.000751	CcSEcCtD
Telaprevir—Rash—Paclitaxel—lung cancer	4.01e-05	0.000748	CcSEcCtD
Telaprevir—Dermatitis—Paclitaxel—lung cancer	4e-05	0.000747	CcSEcCtD
Telaprevir—Asthenia—Docetaxel—lung cancer	3.87e-05	0.000721	CcSEcCtD
Telaprevir—Infection—Methotrexate—lung cancer	3.86e-05	0.00072	CcSEcCtD
Telaprevir—Nausea—Etoposide—lung cancer	3.85e-05	0.000719	CcSEcCtD
Telaprevir—Pruritus—Docetaxel—lung cancer	3.81e-05	0.000711	CcSEcCtD
Telaprevir—Nervous system disorder—Methotrexate—lung cancer	3.81e-05	0.000711	CcSEcCtD
Telaprevir—Anaemia—Doxorubicin—lung cancer	3.81e-05	0.000711	CcSEcCtD
Telaprevir—Thrombocytopenia—Methotrexate—lung cancer	3.8e-05	0.000709	CcSEcCtD
Telaprevir—Nausea—Paclitaxel—lung cancer	3.78e-05	0.000704	CcSEcCtD
Telaprevir—Skin disorder—Methotrexate—lung cancer	3.77e-05	0.000704	CcSEcCtD
Telaprevir—Syncope—Doxorubicin—lung cancer	3.69e-05	0.000689	CcSEcCtD
Telaprevir—Diarrhoea—Docetaxel—lung cancer	3.69e-05	0.000688	CcSEcCtD
Telaprevir—Loss of consciousness—Doxorubicin—lung cancer	3.62e-05	0.000676	CcSEcCtD
Telaprevir—Dizziness—Docetaxel—lung cancer	3.56e-05	0.000665	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	3.48e-05	0.00065	CcSEcCtD
Telaprevir—Vomiting—Docetaxel—lung cancer	3.43e-05	0.000639	CcSEcCtD
Telaprevir—Rash—Docetaxel—lung cancer	3.4e-05	0.000634	CcSEcCtD
Telaprevir—Dermatitis—Docetaxel—lung cancer	3.39e-05	0.000633	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Methotrexate—lung cancer	3.35e-05	0.000626	CcSEcCtD
Telaprevir—Fatigue—Methotrexate—lung cancer	3.35e-05	0.000625	CcSEcCtD
Telaprevir—Infection—Doxorubicin—lung cancer	3.34e-05	0.000623	CcSEcCtD
Telaprevir—Shock—Doxorubicin—lung cancer	3.31e-05	0.000617	CcSEcCtD
Telaprevir—Nervous system disorder—Doxorubicin—lung cancer	3.3e-05	0.000615	CcSEcCtD
Telaprevir—Thrombocytopenia—Doxorubicin—lung cancer	3.29e-05	0.000614	CcSEcCtD
Telaprevir—Skin disorder—Doxorubicin—lung cancer	3.27e-05	0.000609	CcSEcCtD
Telaprevir—Nausea—Docetaxel—lung cancer	3.2e-05	0.000597	CcSEcCtD
Telaprevir—Urticaria—Methotrexate—lung cancer	3.08e-05	0.000576	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Doxorubicin—lung cancer	2.9e-05	0.000542	CcSEcCtD
Telaprevir—Fatigue—Doxorubicin—lung cancer	2.9e-05	0.000541	CcSEcCtD
Telaprevir—Asthenia—Methotrexate—lung cancer	2.79e-05	0.00052	CcSEcCtD
Telaprevir—Pruritus—Methotrexate—lung cancer	2.75e-05	0.000513	CcSEcCtD
Telaprevir—Urticaria—Doxorubicin—lung cancer	2.67e-05	0.000498	CcSEcCtD
Telaprevir—Diarrhoea—Methotrexate—lung cancer	2.66e-05	0.000496	CcSEcCtD
Telaprevir—Dizziness—Methotrexate—lung cancer	2.57e-05	0.000479	CcSEcCtD
Telaprevir—Vomiting—Methotrexate—lung cancer	2.47e-05	0.000461	CcSEcCtD
Telaprevir—Rash—Methotrexate—lung cancer	2.45e-05	0.000457	CcSEcCtD
Telaprevir—Dermatitis—Methotrexate—lung cancer	2.45e-05	0.000456	CcSEcCtD
Telaprevir—Asthenia—Doxorubicin—lung cancer	2.41e-05	0.00045	CcSEcCtD
Telaprevir—Pruritus—Doxorubicin—lung cancer	2.38e-05	0.000444	CcSEcCtD
Telaprevir—Nausea—Methotrexate—lung cancer	2.31e-05	0.00043	CcSEcCtD
Telaprevir—Diarrhoea—Doxorubicin—lung cancer	2.3e-05	0.000429	CcSEcCtD
Telaprevir—Dizziness—Doxorubicin—lung cancer	2.22e-05	0.000415	CcSEcCtD
Telaprevir—Vomiting—Doxorubicin—lung cancer	2.14e-05	0.000399	CcSEcCtD
Telaprevir—Rash—Doxorubicin—lung cancer	2.12e-05	0.000396	CcSEcCtD
Telaprevir—Dermatitis—Doxorubicin—lung cancer	2.12e-05	0.000395	CcSEcCtD
Telaprevir—Nausea—Doxorubicin—lung cancer	2e-05	0.000373	CcSEcCtD
Telaprevir—CMA1—Signaling Pathways—PTEN—lung cancer	7.29e-06	0.000164	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—HSD17B10—lung cancer	7.25e-06	0.000163	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CNDP2—lung cancer	7.24e-06	0.000162	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTM2—lung cancer	7.24e-06	0.000162	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	7.23e-06	0.000162	CbGpPWpGaD
Telaprevir—CTSK—Immune System—PIK3CA—lung cancer	7.09e-06	0.000159	CbGpPWpGaD
Telaprevir—CTSS—Immune System—MAPK3—lung cancer	7.07e-06	0.000159	CbGpPWpGaD
Telaprevir—ALB—Metabolism—MTMR3—lung cancer	7.04e-06	0.000158	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—TF—lung cancer	7.03e-06	0.000158	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—EP300—lung cancer	6.96e-06	0.000156	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PGAM1—lung cancer	6.86e-06	0.000154	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—RAF1—lung cancer	6.83e-06	0.000153	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—SRC—lung cancer	6.76e-06	0.000152	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	6.75e-06	0.000152	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CKB—lung cancer	6.74e-06	0.000151	CbGpPWpGaD
Telaprevir—CTSS—Immune System—EGFR—lung cancer	6.73e-06	0.000151	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	6.73e-06	0.000151	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—PIK3CB—lung cancer	6.67e-06	0.00015	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	6.65e-06	0.000149	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—ITGB1—lung cancer	6.61e-06	0.000148	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—VEGFA—lung cancer	6.59e-06	0.000148	CbGpPWpGaD
Telaprevir—CTSK—Immune System—HRAS—lung cancer	6.56e-06	0.000147	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP2A7—lung cancer	6.54e-06	0.000147	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—STAT3—lung cancer	6.52e-06	0.000146	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NRAS—lung cancer	6.51e-06	0.000146	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	6.51e-06	0.000146	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—AZIN2—lung cancer	6.45e-06	0.000145	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—COL4A3BP—lung cancer	6.45e-06	0.000145	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SDC4—lung cancer	6.4e-06	0.000144	CbGpPWpGaD
Telaprevir—CTSS—Immune System—KRAS—lung cancer	6.36e-06	0.000143	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTM2—lung cancer	6.34e-06	0.000142	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CNDP2—lung cancer	6.34e-06	0.000142	CbGpPWpGaD
Telaprevir—CTSK—Immune System—IL6—lung cancer	6.28e-06	0.000141	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MAPK3—lung cancer	6.23e-06	0.00014	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—MTMR3—lung cancer	6.17e-06	0.000138	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—IL2—lung cancer	6.12e-06	0.000137	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MYC—lung cancer	6.06e-06	0.000136	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	6.04e-06	0.000136	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PGAM1—lung cancer	6.01e-06	0.000135	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—EGFR—lung cancer	5.93e-06	0.000133	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	5.88e-06	0.000132	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	5.87e-06	0.000132	CbGpPWpGaD
Telaprevir—CTSS—Immune System—PIK3CA—lung cancer	5.84e-06	0.000131	CbGpPWpGaD
Telaprevir—ALB—Metabolism—RRM1—lung cancer	5.83e-06	0.000131	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTA3—lung cancer	5.83e-06	0.000131	CbGpPWpGaD
Telaprevir—CTSK—Immune System—AKT1—lung cancer	5.79e-06	0.00013	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP2A7—lung cancer	5.73e-06	0.000129	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	5.69e-06	0.000128	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	5.67e-06	0.000127	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SDC4—lung cancer	5.61e-06	0.000126	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—KRAS—lung cancer	5.6e-06	0.000126	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—AVP—lung cancer	5.56e-06	0.000125	CbGpPWpGaD
Telaprevir—ALB—Metabolism—B4GALT5—lung cancer	5.48e-06	0.000123	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ATP5H—lung cancer	5.48e-06	0.000123	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—POMC—lung cancer	5.47e-06	0.000123	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	5.41e-06	0.000121	CbGpPWpGaD
Telaprevir—CTSS—Immune System—HRAS—lung cancer	5.4e-06	0.000121	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—ABCB1—lung cancer	5.39e-06	0.000121	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—SRC—lung cancer	5.34e-06	0.00012	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTA4—lung cancer	5.34e-06	0.00012	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	5.26e-06	0.000118	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	5.21e-06	0.000117	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—VEGFA—lung cancer	5.21e-06	0.000117	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTA2—lung cancer	5.2e-06	0.000117	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IL6—lung cancer	5.17e-06	0.000116	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PIK3CA—lung cancer	5.15e-06	0.000115	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—MMP1—lung cancer	5.14e-06	0.000115	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	5.13e-06	0.000115	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—RRM1—lung cancer	5.11e-06	0.000115	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTA3—lung cancer	5.11e-06	0.000115	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTA1—lung cancer	5.02e-06	0.000113	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TP53—lung cancer	4.98e-06	0.000112	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ABCC3—lung cancer	4.96e-06	0.000111	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—MAPK3—lung cancer	4.92e-06	0.000111	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—APOA1—lung cancer	4.91e-06	0.00011	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PLBD1—lung cancer	4.89e-06	0.00011	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	4.87e-06	0.000109	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	4.85e-06	0.000109	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—B4GALT5—lung cancer	4.81e-06	0.000108	CbGpPWpGaD
Telaprevir—ALB—Metabolism—AKR1C1—lung cancer	4.8e-06	0.000108	CbGpPWpGaD
Telaprevir—CTSS—Immune System—AKT1—lung cancer	4.77e-06	0.000107	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—HRAS—lung cancer	4.76e-06	0.000107	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	4.72e-06	0.000106	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTA4—lung cancer	4.67e-06	0.000105	CbGpPWpGaD
Telaprevir—ALB—Metabolism—UGT1A1—lung cancer	4.66e-06	0.000105	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	4.61e-06	0.000104	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IL6—lung cancer	4.56e-06	0.000102	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTA2—lung cancer	4.56e-06	0.000102	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GNG11—lung cancer	4.5e-06	0.000101	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CG—lung cancer	4.49e-06	0.000101	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—APOA1—lung cancer	4.47e-06	0.0001	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—HSD17B10—lung cancer	4.47e-06	0.0001	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—EGF—lung cancer	4.43e-06	9.95e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTA1—lung cancer	4.4e-06	9.87e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	4.36e-06	9.78e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ABCC3—lung cancer	4.35e-06	9.75e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ALDOA—lung cancer	4.28e-06	9.61e-05	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—APOA1—lung cancer	4.25e-06	9.55e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—AKR1C1—lung cancer	4.21e-06	9.45e-05	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—AKT1—lung cancer	4.2e-06	9.44e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—CREBBP—lung cancer	4.16e-06	9.34e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NCOA3—lung cancer	4.16e-06	9.33e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CKB—lung cancer	4.16e-06	9.33e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—UGT1A1—lung cancer	4.09e-06	9.17e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	4.08e-06	9.17e-05	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	4.07e-06	9.13e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ABCG2—lung cancer	4.04e-06	9.08e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ADCY1—lung cancer	4.04e-06	9.08e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	4e-06	8.99e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—HPGDS—lung cancer	3.97e-06	8.9e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ENO2—lung cancer	3.97e-06	8.9e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CD—lung cancer	3.94e-06	8.85e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PPP2R1B—lung cancer	3.94e-06	8.84e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GNG11—lung cancer	3.94e-06	8.84e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTM2—lung cancer	3.91e-06	8.77e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CNDP2—lung cancer	3.91e-06	8.77e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—POMC—lung cancer	3.89e-06	8.73e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	3.87e-06	8.69e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTT1—lung cancer	3.85e-06	8.63e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP2A6—lung cancer	3.8e-06	8.53e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GCLC—lung cancer	3.8e-06	8.53e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—MTMR3—lung cancer	3.8e-06	8.53e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	3.79e-06	8.5e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ALDOA—lung cancer	3.75e-06	8.42e-05	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	3.73e-06	8.37e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PGAM1—lung cancer	3.7e-06	8.31e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NCOA3—lung cancer	3.64e-06	8.17e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ENO1—lung cancer	3.6e-06	8.09e-05	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	3.6e-06	8.08e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.59e-06	8.06e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ADCY1—lung cancer	3.54e-06	7.95e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ABCG2—lung cancer	3.54e-06	7.95e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP2A7—lung cancer	3.53e-06	7.93e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—RAF1—lung cancer	3.52e-06	7.9e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ENO2—lung cancer	3.47e-06	7.8e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—HPGDS—lung cancer	3.47e-06	7.8e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SDC4—lung cancer	3.46e-06	7.76e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PPP2R1B—lung cancer	3.45e-06	7.75e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CB—lung cancer	3.44e-06	7.72e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTT1—lung cancer	3.37e-06	7.56e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GCLC—lung cancer	3.33e-06	7.48e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP2A6—lung cancer	3.33e-06	7.48e-05	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	3.32e-06	7.45e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	3.27e-06	7.34e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP2E1—lung cancer	3.23e-06	7.26e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NQO1—lung cancer	3.2e-06	7.17e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ENO1—lung cancer	3.16e-06	7.09e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IL2—lung cancer	3.16e-06	7.09e-05	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	3.15e-06	7.08e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—RRM1—lung cancer	3.15e-06	7.07e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTA3—lung cancer	3.15e-06	7.07e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.13e-06	7.02e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.1e-06	6.96e-05	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	3.05e-06	6.84e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—B4GALT5—lung cancer	2.96e-06	6.65e-05	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	2.95e-06	6.63e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—STK11—lung cancer	2.88e-06	6.47e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTA4—lung cancer	2.88e-06	6.46e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—EP300—lung cancer	2.83e-06	6.36e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP2E1—lung cancer	2.83e-06	6.36e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTA2—lung cancer	2.81e-06	6.3e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NQO1—lung cancer	2.8e-06	6.29e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—SRC—lung cancer	2.75e-06	6.18e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTA1—lung cancer	2.71e-06	6.08e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.7e-06	6.07e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—VEGFA—lung cancer	2.68e-06	6.02e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ABCC3—lung cancer	2.68e-06	6.01e-05	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	2.67e-06	5.99e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTP1—lung cancer	2.67e-06	5.98e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—NRAS—lung cancer	2.65e-06	5.95e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CAT—lung cancer	2.59e-06	5.82e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—AKR1C1—lung cancer	2.59e-06	5.82e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.58e-06	5.79e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—MAPK3—lung cancer	2.54e-06	5.7e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—STK11—lung cancer	2.52e-06	5.67e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ABCB1—lung cancer	2.52e-06	5.66e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—UGT1A1—lung cancer	2.52e-06	5.65e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—TYMS—lung cancer	2.48e-06	5.56e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTM1—lung cancer	2.45e-06	5.5e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GNG11—lung cancer	2.43e-06	5.45e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTP1—lung cancer	2.34e-06	5.24e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP1A1—lung cancer	2.32e-06	5.21e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ALDOA—lung cancer	2.31e-06	5.19e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ERCC2—lung cancer	2.3e-06	5.17e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—KRAS—lung cancer	2.28e-06	5.12e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CAT—lung cancer	2.27e-06	5.1e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NCOA3—lung cancer	2.24e-06	5.04e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ADCY1—lung cancer	2.18e-06	4.9e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ABCG2—lung cancer	2.18e-06	4.9e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—TYMS—lung cancer	2.17e-06	4.87e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTM1—lung cancer	2.15e-06	4.82e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ENO2—lung cancer	2.14e-06	4.8e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—HPGDS—lung cancer	2.14e-06	4.8e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PPP2R1B—lung cancer	2.13e-06	4.77e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CA—lung cancer	2.1e-06	4.7e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTT1—lung cancer	2.08e-06	4.66e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP2A6—lung cancer	2.05e-06	4.61e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GCLC—lung cancer	2.05e-06	4.61e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP1A1—lung cancer	2.03e-06	4.57e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TP53—lung cancer	2.03e-06	4.55e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ERCC2—lung cancer	2.02e-06	4.53e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—APOA1—lung cancer	1.99e-06	4.47e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ENO1—lung cancer	1.95e-06	4.37e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—HRAS—lung cancer	1.94e-06	4.35e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.91e-06	4.28e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CG—lung cancer	1.82e-06	4.08e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—APOA1—lung cancer	1.75e-06	3.92e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP2E1—lung cancer	1.74e-06	3.92e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—POMC—lung cancer	1.73e-06	3.89e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NQO1—lung cancer	1.73e-06	3.87e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—AKT1—lung cancer	1.71e-06	3.84e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CREBBP—lung cancer	1.69e-06	3.79e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CD—lung cancer	1.6e-06	3.59e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CG—lung cancer	1.59e-06	3.58e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—STK11—lung cancer	1.56e-06	3.49e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—POMC—lung cancer	1.52e-06	3.41e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CREBBP—lung cancer	1.48e-06	3.32e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTP1—lung cancer	1.44e-06	3.23e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CD—lung cancer	1.4e-06	3.14e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CAT—lung cancer	1.4e-06	3.14e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CB—lung cancer	1.39e-06	3.13e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ALB—lung cancer	1.38e-06	3.1e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PTGS2—lung cancer	1.38e-06	3.1e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ABCB1—lung cancer	1.36e-06	3.06e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—TYMS—lung cancer	1.34e-06	3e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTM1—lung cancer	1.32e-06	2.97e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP1A1—lung cancer	1.25e-06	2.81e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ERCC2—lung cancer	1.24e-06	2.79e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CB—lung cancer	1.22e-06	2.74e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PTGS2—lung cancer	1.21e-06	2.72e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PTEN—lung cancer	1.2e-06	2.7e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—EP300—lung cancer	1.15e-06	2.58e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—APOA1—lung cancer	1.08e-06	2.41e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PTEN—lung cancer	1.06e-06	2.37e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—EP300—lung cancer	1.01e-06	2.26e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CG—lung cancer	9.82e-07	2.2e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—POMC—lung cancer	9.35e-07	2.1e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CREBBP—lung cancer	9.1e-07	2.04e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CD—lung cancer	8.63e-07	1.94e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ALB—lung cancer	8.52e-07	1.91e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CA—lung cancer	8.5e-07	1.91e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CB—lung cancer	7.52e-07	1.69e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PTGS2—lung cancer	7.46e-07	1.67e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CA—lung cancer	7.44e-07	1.67e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—AKT1—lung cancer	6.94e-07	1.56e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PTEN—lung cancer	6.5e-07	1.46e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—EP300—lung cancer	6.2e-07	1.39e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—AKT1—lung cancer	6.08e-07	1.37e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CA—lung cancer	4.59e-07	1.03e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—AKT1—lung cancer	3.75e-07	8.41e-06	CbGpPWpGaD
